Skip to main content
logo
LIR Life Sciences Corp. (CSE:SKNY)
Canada flag Canada · Delayed Price · Currency is CAD
0.1800
-0.0200 (-10.00%)
At close: Sep 18, 2026

LIR Life Sciences Cash Flow Statement

Millions CAD. Fiscal year is May - Apr.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Net Income
-3.9-0.42-0.08
Depreciation & Amortization
0--
Asset Writedown & Restructuring Costs
0.1--
Stock-Based Compensation
1.59--
Other Operating Activities
0.33--
Change in Accounts Receivable
-0.01-0.03
Change in Accounts Payable
-0.060.170.11
Change in Other Net Operating Assets
-0.11--
Operating Cash Flow
-2.04-0.250
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Cash Acquisitions
1.52--
Sale (Purchase) of Intangibles
-0.11--
Investing Cash Flow
1.41--

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Short-Term Debt Issued
0.040.06-
Total Debt Issued
0.040.060.58
Short-Term Debt Repaid
--0.26-
Total Debt Repaid
--0.26-
Net Debt Issued (Repaid)
0.04-0.190.58
Issuance of Common Stock
1.070.380
Repurchase of Common Stock
-0-0-
Other Financing Activities
-0-0.01-
Financing Cash Flow
1.10.170.58

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Net Cash Flow
0.48-0.070.59

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Levered Free Cash Flow
-0.92-0.09-
Unlevered Free Cash Flow
-0.92-0.09-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024
Period Ending
Apr '26 Apr '25 Apr '24
Change in Working Capital
-0.170.180.08